Medical Disclaimer: This article examines the observed associations between periodontal disease and rheumatoid arthritis (RA), as reported in scientific literature. It discusses emerging research hypotheses and is for informational and educational purposes only. This is not medical advice and does not constitute a treatment recommendation. Rheumatoid arthritis is a serious autoimmune disease that must be diagnosed and managed by a rheumatologist. Any changes to your health regimen must be discussed with your healthcare providers.

For individuals living with rheumatoid arthritis (RA), the journey involves managing joint pain, stiffness, and systemic inflammation. Treatment typically focuses on medications like DMARDs and biologics. However, a growing area of scientific investigation explores whether addressing chronic oral inflammation—specifically periodontal (gum) disease—could play a supportive role in overall disease management by influencing systemic inflammatory load.

Rethinking Oral Health in Systemic Inflammation

The traditional view of the mouth as separate from the body is evolving. RA is a systemic autoimmune condition. A key scientific hypothesis suggests that significant, persistent sources of inflammation elsewhere in the body—such as chronic gum disease—may contribute to the body’s overall inflammatory burden. Managing these peripheral sources is being studied as a potential component of a comprehensive inflammatory management strategy.

Porphyromonas gingivalis and the Citrullination Hypothesis

A focal point of research is the bacterium Porphyromonas gingivalis (P. gingivalis), associated with severe gum disease. This bacterium produces an enzyme (PPAD) that can alter human proteins in a process called citrullination. In RA, the immune system often mistakenly attacks these citrullinated proteins. The scientific hypothesis is that the citrullination triggered by oral bacteria in the gums may, in genetically susceptible individuals, contribute to this autoimmune response. This represents an active area of immunological research, not an established cause for all RA cases.

Professional Periodontal Therapy: The Standard Dental Intervention

The primary dental treatment for periodontitis is non-surgical periodontal therapy, such as scaling and root planing (SRP). This is a deep cleaning procedure performed by dental professionals to remove bacterial biofilm and calculus from below the gumline, with the goal of reducing local inflammation and improving oral health.

Reviewing the Clinical Research

Several clinical studies and systematic reviews have investigated whether periodontal therapy in patients with RA is associated with changes in disease activity markers. Some observational studies and preliminary trials have reported correlations between SRP and:

  • Modest improvements in disease activity scores (e.g., DAS28).
  • Reductions in certain systemic inflammatory markers (e.g., CRP, ESR).

It is critically important to interpret this cautiously: This research does not establish that gum therapy is a treatment for RA or that it can slow disease progression on its own. The findings support the concept that reducing one source of chronic inflammation may have beneficial effects on systemic inflammatory markers, which could theoretically support overall disease management.

Potential Mechanisms and Integrated Care

The proposed biological rationale is that by reducing the bacterial load and local inflammation in the gums, the stimulus for systemic immune activation may be lessened. This could potentially help lower the background level of inflammation against which RA exists.

This research underscores the potential value of collaboration between rheumatologists and dental professionals.

  • For Patients with RA: Discuss your oral health with your rheumatologist. Inform your dentist or periodontist about your RA diagnosis and medications.
  • For Healthcare Providers: A holistic view that includes assessment and management of periodontal health may be a valuable consideration in the comprehensive care plan for a patient with RA.

A Nuanced View on Management

Managing RA effectively requires a plan led by your rheumatologist, including prescribed medications and lifestyle strategies. Professional dental care is not a substitute for this medical treatment.

The emerging science suggests that optimal periodontal health should be considered an important component of general health maintenance for individuals with RA, as it is for everyone. Controlling oral inflammation may help manage the body’s total inflammatory load.

Your Most Important Step: Coordinated Professional Care

If you have rheumatoid arthritis, your rheumatologist is your guide for disease management. If you have signs of gum disease—such as bleeding, swelling, or persistent bad breath—consult a dentist or periodontist.

The goal is integrated care, not replacement. Ensure both your rheumatologist and your dental provider are fully informed and communicating. This collaborative approach allows your entire healthcare team to develop the most comprehensive strategy for managing inflammation and protecting your long-term health.


This article reviews associations and hypotheses from current scientific literature. Individual treatment decisions must be made in consultation with your qualified healthcare team.


References

1. Inchingolo, F., Inchingolo, A.M., Avantario, P., Settanni, V., Fatone, M.C., Piras, F., Di Venere, D., Inchingolo, A.D., Palermo, A. and Dipalma, G., 2023. The effects of periodontal treatment on rheumatoid arthritis and of anti-rheumatic drugs on periodontitis: a systematic review. International journal of molecular sciences24(24), p.17228.

2. Ortiz, P., Bissada, N.F., Palomo, L., Han, Y.W., Al‐Zahrani, M.S., Panneerselvam, A. and Askari, A., 2009. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. Journal of periodontology80(4), pp.535-540.

3. Fuggle, N.R., Smith, T.O., Kaul, A. and Sofat, N., 2016. Hand to mouth: a systematic review and meta-analysis of the association between rheumatoid arthritis and periodontitis. Frontiers in immunology7, p.80.

4. Qi, X.Y., Liu, M.X., Jiang, X.J., Gao, T., Xu, G.Q., Zhang, H.Y., Su, Q.Y., Du, Y., Luo, J. and Zhang, S.X., 2025. Gut microbiota in rheumatoid arthritis: Mechanistic insights, clinical biomarkers, and translational perspectives. Autoimmunity Reviews, p.103912.

5.  Mikuls, T.R., Walker, C., Qiu, F., Yu, F., Thiele, G.M., Alfant, B., Li, E.C., Zhao, L.Y., Wang, G.P., Datta, S. and Payne, J.B., 2018. The subgingival microbiome in patients with established rheumatoid arthritis. Rheumatology57(7), pp.1162-1172.

The Periodontal Professor — Prof. Solomon O. Nwhator, BDS (Lagos), PhD (Helsinki), FMCDS, FWACS, Professor of Periodontal Medicine


Leave a Reply

Your email address will not be published. Required fields are marked *

Verified by MonsterInsights